MX2018000353A - Sistema vector de adenovirus aviar 9 (fadv-9) y metodos asociados. - Google Patents

Sistema vector de adenovirus aviar 9 (fadv-9) y metodos asociados.

Info

Publication number
MX2018000353A
MX2018000353A MX2018000353A MX2018000353A MX2018000353A MX 2018000353 A MX2018000353 A MX 2018000353A MX 2018000353 A MX2018000353 A MX 2018000353A MX 2018000353 A MX2018000353 A MX 2018000353A MX 2018000353 A MX2018000353 A MX 2018000353A
Authority
MX
Mexico
Prior art keywords
fadv
vectors
associated methods
fowl adenovirus
vector system
Prior art date
Application number
MX2018000353A
Other languages
English (en)
Inventor
Éva Nagy
Pei Yanlong
Ackford James
Carlos CORREDOR Juan
J Krell Peter
Original Assignee
Univ Guelph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Guelph filed Critical Univ Guelph
Publication of MX2018000353A publication Critical patent/MX2018000353A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen vectores virales recombinantes obtenidos de adenovirus aviar 9 (FAdV-9) y métodos asociados; los vectores FAdV-9 recombinantes pueden incluir una o más supresiones en el extremo izquierdo y/o extremo derecho del genoma de FAdV-9; opcionalmente, los vectores incluyen una o más secuencias de nucleótidos exógenas, tales como secuencias que codifican un polipéptido de interés; los vectores FAdV-9 recombinantes se pueden usar como un vector de suministro doble; también se describe el uso de los vectores para generar una respuesta inmunogénica en un sujeto y/o para prevenir una enfermedad.
MX2018000353A 2015-07-10 2016-07-11 Sistema vector de adenovirus aviar 9 (fadv-9) y metodos asociados. MX2018000353A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562190913P 2015-07-10 2015-07-10
PCT/CA2016/050811 WO2017008154A1 (en) 2015-07-10 2016-07-11 Fowl adenovirus 9 (fadv-9) vector system and associated methods

Publications (1)

Publication Number Publication Date
MX2018000353A true MX2018000353A (es) 2018-03-14

Family

ID=57756612

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000353A MX2018000353A (es) 2015-07-10 2016-07-11 Sistema vector de adenovirus aviar 9 (fadv-9) y metodos asociados.

Country Status (11)

Country Link
US (2) US20190153470A1 (es)
EP (1) EP3320100B1 (es)
BR (1) BR112018000194A2 (es)
CA (1) CA2991925A1 (es)
CO (1) CO2018001339A2 (es)
EA (1) EA201890274A1 (es)
IL (1) IL256801B (es)
MX (1) MX2018000353A (es)
PE (1) PE20181087A1 (es)
WO (1) WO2017008154A1 (es)
ZA (1) ZA201800705B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
WO2021202331A1 (en) * 2020-03-29 2021-10-07 Greffex, Inc. Replication-deficient avian adenoviral vectors, their design and uses
CN112094824B (zh) * 2020-08-19 2021-04-20 湖北省农业科学院畜牧兽医研究所 表达禽腺病毒4型截短Fiber2蛋白的重组新城疫病毒耐热疫苗株及其制备方法与应用
CN113584231B (zh) * 2021-09-10 2024-04-19 广西壮族自治区兽医研究所 鉴定i群禽腺病毒血清8型的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296852B1 (en) * 1993-04-14 2001-10-02 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
DE19615803A1 (de) * 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
US6841158B1 (en) * 1998-09-22 2005-01-11 Boehringer Ingelheim International Gmbh Recombinant celo virus and celo virus DNA
RU2528750C2 (ru) * 2008-11-19 2014-09-20 Лабораторио Ави-Мекс, С.А. Де С.В. Рекомбинантная вакцина на основе инактивированного вирусного вектора

Also Published As

Publication number Publication date
BR112018000194A2 (pt) 2018-09-11
IL256801A (en) 2018-03-29
IL256801B (en) 2021-10-31
EA201890274A1 (ru) 2018-08-31
ZA201800705B (en) 2018-12-19
WO2017008154A1 (en) 2017-01-19
US20210317476A1 (en) 2021-10-14
EP3320100A4 (en) 2018-12-26
CO2018001339A2 (es) 2018-04-30
EP3320100B1 (en) 2024-08-28
PE20181087A1 (es) 2018-07-09
US20190153470A1 (en) 2019-05-23
EP3320100A1 (en) 2018-05-16
CA2991925A1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
SA518400623B1 (ar) جينات ديستروفين صغير محسنة ومجموعات إظهارها واستخدامها
PH12019501130A1 (en) Viral delivery of neoantigens
MX2022005291A (es) Vacunas para el tratamiento y prevencion del cancer.
MX2018016074A (es) Vector adenoviral.
MX2018001213A (es) Nuevos metodos para inducir una respuesta inmunitaria.
SA518390954B1 (ar) لقاحات علاجية لفيروس الورم الحليمي البشري 18
MX2022006602A (es) Vacunas de herpesvirus de pavo recombinante y uso de las mismas.
MX2018000353A (es) Sistema vector de adenovirus aviar 9 (fadv-9) y metodos asociados.
WO2019056015A3 (en) STRONG ISOLATOR AND ITS USES IN GENE ADMINISTRATION
ES2722773T3 (es) Polipéptidos de fHbp meningocócicos modificados
PH12017500216B1 (en) Vaccine in serotype-9 fowl adenovirus recombinant vector
PH12016501689A1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
NZ751014A (en) New ehv insertion site orf70
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
PH12019500578A1 (en) New promoters
PH12017500419B1 (en) Recoded arbovirus and vaccines
PH12020500526A1 (en) Paramyxoviridae expression system
MX2021005435A (es) Transgen abcb11 con codones optimizados para el tratamiento de colestasis intrahepatica familiar progresiva tipo 2 (pfic2).
NZ765719A (en) Adeno-associated virus (aav) vector having hybrid hgf gene introduced thereto
WO2016011432A3 (en) Identification of immunogenic mhc class ii peptides for immune-based therapy
CA3045626A1 (en) Bovine herpesvirus type 1 (bohv-1) vector against bovine respiratory disease complex
NZ618125A (en) Genetic vaccines against hendra virus and nipah virus
MX2015011064A (es) Vacuna contra el virus de la leucemia bovina.
MX2020008779A (es) Sistemas de vectores virales recombinantes que expresan genes de paramixovirus felino exogenos y vacunas elaboradas a partir de estos.
MX2017013473A (es) Agente inductor de inmunidad.